Fulgent Genetics, INC Form 4 insider transactions

Fulgent Genetics' President and COO, Jian Xie, sold 1,140 shares of common stock to cover tax liabilities from vested restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,075 shares of common stock to cover tax liabilities from vested restricted stock units.

Fulgent Genetics President and COO Jian Xie sold 1,198 shares of common stock to cover tax liabilities from vested restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 943 shares of common stock on November 28, 2025, to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics' CFO and Treasurer, Paul Kim, disposed of 1,166 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics CEO Ming Hsieh disposed of 2,944 shares of common stock at $30.15 per share to cover tax liabilities from RSU vesting.

Fulgent Genetics CFO Paul Kim reported a routine disposition of 671 common shares to cover tax obligations from vested restricted stock units.

Fulgent Genetics President and COO, Jian Xie, sold 681 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 535 shares of common stock to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics CEO Ming Hsieh disposed of 2,116 shares of common stock to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics' President and COO, Jian Xie, reported the sale of 10,000 shares for tax planning and gifted another 10,000 shares to a family foundation.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, disposed of 1,642 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Fulgent Genetics' CFO, Paul Kim, disposed of 2,743 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics President and COO Jian Xie disposed of 4,353 shares of common stock to cover tax obligations related to RSU vesting.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,063 shares of common stock at a weighted-average price of $22.0267 to cover tax withholding obligations from RSU vesting.

Fulgent Genetics President and COO, Xie Jian, sold 1,128 shares of common stock to satisfy tax obligations related to vested restricted stock units.

Fulgent Genetics CFO Paul Kim disposed of 1,131 common shares at $22.17 each to satisfy tax withholding obligations related to restricted stock unit vesting.

Fulgent Genetics' President and COO, Jian Xie, reported the sale of 1,199 common shares on August 27, 2025, to cover tax withholdings from RSU vesting.

Fulgent Genetics CEO Ming Hsieh reported the withholding of 2,944 shares to cover tax obligations from restricted stock unit vesting.

Fulgent Genetics CFO Paul Kim disposed of 1,166 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 943 shares of common stock for $21.4847 per share to cover tax withholding obligations from RSU vesting.

Fulgent Genetics' President and COO, Jian Xie, sold 696 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics CEO Ming Hsieh disposed of 2,115 shares of common stock to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics' CFO, Paul Kim, disposed of 670 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 548 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics CEO Ming Hsieh reported a disposition of shares to cover tax obligations from vested restricted stock units.

Fulgent Genetics' CFO and Treasurer, Paul Kim, reported the disposition of 2,743 shares of common stock valued at $18.37 per share to cover tax withholding obligations from restricted stock unit vesting.

Fulgent Genetics, Inc.'s President and COO, Jian Xie, reported the disposition of 4,352 shares of common stock at $18.37 per share to cover tax withholding obligations related to restricted stock unit vesting.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, reported a future disposition of 1,642 common shares at $18.37 each to cover tax obligations related to restricted stock unit vesting.

The Ming Hsieh Trust, associated with Fulgent Genetics CEO Ming Hsieh, has paid over $16.4 million to cancel a prepaid variable forward agreement, regaining control of 800,000 shares of Fulgent Genetics common stock.